Daiwa Securities Group Inc. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4
-20.0%
630.0%0.00%
Q2 2023$50.0%630.0%0.00%
Q1 2023$5
+25.0%
630.0%0.00%
Q4 2022$4
-99.9%
630.0%0.00%
Q3 2022$5,000
-16.7%
630.0%0.00%
Q2 2022$6,0000.0%63
+28.6%
0.00%
Q1 2022$6,000
-25.0%
490.0%0.00%
Q4 2021$8,0000.0%49
-14.0%
0.00%
Q3 2021$8,000
+100.0%
57
+72.7%
0.00%
Q2 2021$4,000
-20.0%
330.0%0.00%
Q1 2021$5,000
+66.7%
33
+10.0%
0.00%
Q4 2020$3,000
-66.7%
30
-67.4%
0.00%
Q3 2020$9,000
+28.6%
920.0%0.00%
Q2 2020$7,0000.0%920.0%0.00%
Q1 2020$7,000
-30.0%
92
-7.1%
0.00%
Q4 2019$10,000
-16.7%
99
-19.5%
0.00%
Q3 2019$12,000
-14.3%
1230.0%0.00%
Q2 2019$14,000
-12.5%
123
-5.4%
0.00%
Q1 2019$16,0000.0%130
+11.1%
0.00%
Q4 2018$16,000
-50.0%
1170.0%0.00%
Q3 2018$32,000
+33.3%
1170.0%0.00%
Q2 2018$24,000
+26.3%
1170.0%0.00%
Q1 2018$19,0001170.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders